Ivan Dominguez, MD
Vascular Surgery · San Juan, PRNPI 1104070705
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Endologix LLC at 53.1% of the total. Reporting peaked in 2019 at $25,906 and has fallen 75.5% since, to $6,344 in 2025. Among vascular surgery clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $242.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$20K
- Boston Scientific$9K
- EKOS Corporation$5K
- W. L. Gore & Associates, Inc.$1K
- Medtronic$431
- Johnson & Johnson$387
- plus $1K from 17 others
What the payments were for
- Consulting fees$14,10038%
- Speaking & faculty fees$11,70032%
- Travel & lodging$5,89316%
- Food & beverage$5,11114%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 42 | $19,536 |
| Boston Scientific | 50 | $9,447 |
| EKOS Corporation | 6 | $4,643 |
| W. L. Gore & Associates, Inc. | 5 | $1,319 |
| Medtronic | 9 | $431 |
| Johnson & Johnson | 11 | $387 |
| Shape Memory Medical Inc. | 3 | $333 |
| Inari Medical, Inc. | 3 | $131 |
| Lemaitre Vascular, Inc. | 1 | $118 |
| E.r. Squibb & Sons, L.L.C. | 3 | $79 |
| Hologic Sales And Service, LLC | 3 | $75 |
| Abbott | 3 | $56 |
| Bard Peripheral Vascular, Inc. | 2 | $50 |
| Boehringer Ingelheim | 2 | $45 |
| Edwards Lifesciences | 1 | $24 |
| PBG Puerto Rico LLC | 1 | $22 |
| Silk Road Medical, Inc. | 1 | $21 |
| Philips North America LLC | 1 | $19 |
| Chiesi USA, Inc. | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
| Cardinal Health P.r. 120 Inc | 1 | $12 |
| Polarityte, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFX$12,574
- Ovation$9,740
- ELUVIA$5,700
- EKOSONIC$4,554
- AngioJet Ultra 5000A$2,500
- TIGRIS Stent$1,200
- IMPEDE EMBOLIZATION PLUG$286
- ENDURANT IIS$151
- XARELTO$118
- ARTEGRAFT VASCULAR GRAFT$118
- SYMPLICITY G3$111
- ANGIOJET$101
How this compares
$36,804 in reported general payments places this provider in the 90th percentile of 20 vascular surgery providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $31,012 |
| ClopidogrelClopidogrel Bisulfate | 236 | $2,121 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $31,01246 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 20 vascular surgery providers in Puerto Rico.
Other vascular surgery in San Juan
- Fernando Joglar-IrizarrySan Juan$48K
- Cesar Castillo AliceaSan Juan$10K
- Francisco Aponte RiveraSan Juan$742
- Agustin Rodriguez GonzalezSan Juan$709
- Carlos Calimano GuardiolaSan Juan$526
- Leonardo ValentinManati$12K
- Gabriel Pereira TorrellasPonce$9K
- Jorge Martinez TrabalPonce$8K
- Rafael Santini DominguezPonce$8K
- Angel Menendez-AponteBayamon$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.